BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Pharm Country

  CytoSorbents, Inc. Reports Temporary Change Of Stock Trading Symbol

  December 8, 2014

   · 

  3 min read
• Drug Development

  Agios Pharmaceuticals Announces New Data From Ongoing Phase 1 Trial Of AG-221 Showing Robust Clinical Activity In Patients With Advanced Hematologic Malignancies

  December 8, 2014

   · 

  14 min read
• Drug Development

  Amgen Announces New Data From Phase 2 BLINCYTO (blinatumomab) Immunotherapy Study In Patients With Acute Lymphoblastic Leukemia And Minimal Residual Disease

  December 8, 2014

   · 

  15 min read
• Drug Development

  Children’s Hospital of Philadelphia Release: Benefits Persist In T Cell Therapy For Children With Relapsed Leukemia

  December 8, 2014

   · 

  5 min read
• Drug Development

  American Society of Hematology Release: Novel Combinations Of New And Existing Therapies Yield Promising Results for Leukemia Patients With Poor Prognoses

  December 8, 2014

   · 

  17 min read
• Drug Development

  VaxInnate Corporation Initiates Phase 1b/2 Clinical Trial Of Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, In Elderly

  December 8, 2014

   · 

  4 min read
• BioMidwest

  BioAdaptives Announces New Trial Showing PrimiCell Improved Muscle Repair By Over 56%

  December 8, 2014

   · 

  3 min read
• Deals

  Tecomet, Inc. Acquires Symmetry Medical Inc. OEM Solutions Business

  December 8, 2014

   · 

  2 min read
• Pharm Country

  Advaxis, Inc. Announces FDA Acceptance Of Its Investigational New Drug Application To Commence Clinical Trials Of ADXS-PSA In Combination With Merck & Co.'s KEYTRUDA® (Pembrolizumab) For Prostate Cancer

  December 8, 2014

   · 

  7 min read
• Biotech Bay

  American Society of Hematology Release: Studies Compare Blood Clot Treatments, Illuminate Recurrence Risk In High-Risk Groups

  December 8, 2014

   · 

  11 min read